795 related articles for article (PubMed ID: 32643552)
1. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an
Chikhale RV; Gurav SS; Patil RB; Sinha SK; Prasad SK; Shakya A; Shrivastava SK; Gurav NS; Prasad RS
J Biomol Struct Dyn; 2021 Aug; 39(12):4510-4521. PubMed ID: 32568012
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
Ghosh A; Chakraborty M; Chandra A; Alam MP
J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of SARS-CoV-2 main protease (M
Verma S; Patel CN; Chandra M
J Comput Chem; 2021 Oct; 42(26):1861-1872. PubMed ID: 34287986
[TBL] [Abstract][Full Text] [Related]
6.
Singh M; Jayant K; Singh D; Bhutani S; Poddar NK; Chaudhary AA; Khan SU; Adnan M; Siddiqui AJ; Hassan MI; Khan FI; Lai D; Khan S
Front Cell Infect Microbiol; 2022; 12():933824. PubMed ID: 36046742
[TBL] [Abstract][Full Text] [Related]
7. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
8. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
9.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
10. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
Ancy I; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
[TBL] [Abstract][Full Text] [Related]
11. Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study.
Kushwaha PP; Singh AK; Prajapati KS; Shuaib M; Gupta S; Kumar S
Microb Pathog; 2021 Aug; 157():104954. PubMed ID: 34033891
[TBL] [Abstract][Full Text] [Related]
12. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M
Kumar V; Dhanjal JK; Kaul SC; Wadhwa R; Sundar D
J Biomol Struct Dyn; 2021 Jul; 39(11):3842-3854. PubMed ID: 32431217
[TBL] [Abstract][Full Text] [Related]
13. The Natural Products Withaferin A and Withanone from the Medicinal Herb
Chakraborty S; Mallick D; Goswami M; Guengerich FP; Chakrabarty A; Chowdhury G
J Nat Prod; 2022 Oct; 85(10):2340-2350. PubMed ID: 36098617
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
Purohit P; Dash JJ; Muya JT; Meher BR
J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
[TBL] [Abstract][Full Text] [Related]
15. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
16. Analysis of medicinal and therapeutic potential of
Gheshlaghi SZ; Nakhaei E; Ebrahimi A; Jafari M; Shahraki A; Rezazadeh S; Saberinasab E; Nowroozi A; Hosseini SS
J Biomol Struct Dyn; 2023; 41(14):6883-6893. PubMed ID: 35993530
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 M
Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
[TBL] [Abstract][Full Text] [Related]
18. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M
J A; Francis D; C S S; K G A; C S; Variyar EJ
J Biomol Struct Dyn; 2022 Jan; 40(1):325-336. PubMed ID: 32873185
[TBL] [Abstract][Full Text] [Related]
19.
Bhargavi S; Madhan Shankar SR; Jemmy CH
J Biomol Struct Dyn; 2023 May; 41(8):3265-3280. PubMed ID: 35257637
[TBL] [Abstract][Full Text] [Related]
20. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
